FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
46 | IS AJCC STAGE IIA MELANOMA A HOMOGENEOUS DISEASE? A 23-YEAR SINGLE-CENTER EXPERIENCE C. Cescatti1, C. Trevisiol2, P. Del Fiore2, G. Madeo3, N. Romagnolo4, F. Cassalia2, A. Acciardi2, S. Mocellin2|3, M. Alaibac4 | 1Department of Medicine (DIMED), School of Medicine, University of Padova, Italy; 2Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Italy; 3Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Italy; 4Dermatology Unit, Department of Medicine, University of Padova, Italy
81PDF: 33 -
32 | BEYOND AREA REDUCTION: PULSED DYE LASER TREATMENT OF BASAL CELL CARCINOMA IN A PRELIMINARY REAL-WORLD COHORT G. Frattin1|2, A. Bolzon1|2, E. Pezzolo1, L. Germi1, L. Gnesotto1, A. Corrà1, G. Mioso1, Z. Fratton1, L. Schiesari1 | 1UOC Dermatologia, Ospedale San Bortolo, Vicenza, Italy; 2Università degli Studi di Padova, Clinica Dermatologica, Italy
106PDF: 39 -
Photoepilation and skin photorejuvenation: an update
2502PDF: 1621HTML: 688 -
10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain
206PDF: 132 -
-
Dermatofibrosarcoma protuberans diagnosed by a single biopsy
3257PDF: 567HTML: 3117 -
27 | Real-world data for malignant melanoma stage II adjuvant therapy Silvana Cozzolino1, Antonino Colloca1, Miriam Forte1, Francesco Caraglia1, Alfonso Esposito1, Maria Cristina Giugliano1, Eleonora Cioli1, Marcella Scala2, Maria Chiara Sergi3, Teresa Del Giudice4, Francesca Sparano5, Immacolata Paciolla6, Mariangela Pasqualoni7, Luigi Formisano2, Stefania Napolitano1, Antonio Maria Grimaldi1, Paolo Antonio Ascierto5, Fortunato Ciardiello1, Teresa Troiani1, Vincenzo De Falco1 | 1Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples; 2Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy; 3Division of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Barletta; 4Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; 5Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples; 6Medical Oncology Unit, AORN "San Pio", Benevento, Italy; 7Medical Oncology Unit, ASL Taranto, Italy.
455 -
41 | METABOLIC DYSREGULATION AND IMMUNE ACTIVATION IN VITILIGO: UNVEILING THE MITOCHONDRIAL AND INFLAMMATORY IMPRINT OF DISEASE PATHOGENESIS S. Caputo1, A. Marini1, S. Scano1, F. Papaccio1, R. Marrapodi1, P. Iacovelli2, A. Presaghi3, E. Migliano3, C. Cota4, A. Filoni5, M. Picardo6, B. Bellei1 | 1Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 2Clinical Dermatology, Phototherapy Unit, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 3Department of Plastic and Regenerative Surgery, San Gallicano Dermatological Institute, IRCCS, Rome, Italy; 4Genetic Research, Molecular Biology and Dermatopathology Unit, San Gallicano Dermatological Institute, Rome, Italy; 5UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; 6Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy
92PDF: 39 -
Underrepresentation of atopic dermatitis publications in pediatric journals: a bibliometric analysis
748PDF: 557SUPPLEMENTARY MATERIAL: 176HTML: 21 -
Microinfusion of medications into the skin as a drug delivery technique: a narrative review
792PDF: 256SUPPLEMENTARY MATERIAL: 105HTML: 8 -
Leser-Trélat sign as a rare manifestation of cutaneous melanoma
1322PDF: 589HTML: 100 -
29 | INNOVATIVE THERAPEUTIC STRATEGIES IN GENODERMATOSIS: AN ITALIAN MULTICENTRE STUDY F. Pavan1, F. Cassalia2, S. Giordano3, A. Gelmetti4, L. Ventura5, F. Caroppo2, A. Bassi6, F. Martorana7, R. Balestri8, A. Guglielmo9, F. Ambrogio10, A. Bonvicino3, I. Neri4, P. Quaglino3, A. Belloni Fortina11 | 1Pediatrics Unit, Department of Women’s and Child’s Health (SDB), University of Padua, Italy; 2Dermatology Unit, Department of Medicine (DIMED), University of Padua, Italy; 3Department of Medical Sciences, Section of Dermatology, University of Turin, Italy; 4Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Italy; 5Department of Statistical Science, University of Padua, Italy; 6Unit of Dermatology, Azienda USL Toscana Nord Ovest, Lucca, Italy; 7Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II; 8Division of Dermatology, Outpatient Consultation for Rare Diseases, APSS, Trento, Italy; 9Institute of Dermatology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy; 10Section of Dermatology and Venereology, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, Italy; 11Pediatric Dermatology Department of Women’s and Child’s Health (SDB), University of Padua, Italy
105PDF: 28 -
A giant benign clear cell hidradenoma on the anterior trunk
1520PDF: 942HTML: 1043 -
23 | Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: an international retrospective study Maria Chiara Sergi*1, Teresa Amaral*2, Piotr Rutkowski*3, Marie-Lena Rasch2, Naima Benannoune4, Patricio Serra5, Maria Grazia Vitale6, Diana Giannarelli7, Ana Maria Arance8, Eva Munoz Couselo9, Bart Neyns10, Iris Dirven11, Marco Tucci12, Michele Guida13, Francesco Spagnolo14, Ernesto Rossi15, Paola Queirolo16, Pietro Quaglino17, Roberta Depenni18, Joanna Placzke3, Anna Maria Di Giacomo19, Michele Del Vecchio20, Alice Indini20, Ines Pires da Silva21, Alexander M. Menzies22, Angela Hong23, Paul Lorigan5, Caroline Robert24, Georgina V. Long22, Paolo A. Ascierto6, Mario Mandalà25 | 1Unit of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Asl BT, Barletta, Italy; 2Skin Cancer Clinical Trials Center, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. 3Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. 4Gustave Roussy Cancer Campus, Villejuif, France. 5The University of Manchester, Manchester, UK. 6Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione "G. Pascale" Napoli, Naples, Italy; 7Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy; 8Hospital Clínic Barcelona and IDIBAPS, Barcelona, Spain; 9Department of medical oncology. Vall d"Hebron Hospital, Barcelona, Spain & Vall d’Hebron Institute of oncology, VHIO. Barcelona, Spain; 10Department of Medical Oncology, UZ Brussel, Brussels, Belgium. 11Department of medical oncology, Vrije Universiteit Brussel, VUB, Universitair Ziekenhuis Brussel, Brussels, Belgium; 12Medical Oncology Unit, University of Bari Aldo Moro, Policlinico Hospital of Bari, 70124 Bari, Italy. 13Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori "Giovanni Paolo II," Bari, Italy. 14IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy; 15Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy; 16IEO European Institute of Oncology, IRCCS, Milan, Italy. 17Department of Dermatology, University of Turin, Turin, Italy. 18University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy; 19Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy. 20Unit of Melanoma Medical Oncology, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 21Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia; 22Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia; 23Faculty of Medicine and Health, Sydney Medical School, The University of Sydney, Australia; Department of Radiation Oncology, Chris O'Brien Lifehouse, Camperdown, NSW, Australia; 24Gustave Roussy and Paris-Saclay University, Villejuif, France; 25Unit of Medical Oncology, University of Perugia, Perugia, Italy. § on behalf of the Italian Melanoma Intergroup - IMI.
413 -
Tight junctions in Hailey-Hailey and Darier’s diseases
1695PDF: 691HTML: 1737
